Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MK-3475 in Combination With Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma

NCT02541565 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02541565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MK-3475 in Combination With Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Completed
Start date
November 24, 2015
Completion date
December 18, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

composite lymphoma, grade 3b follicular lymphoma, stage i diffuse large b-cell lymphoma, stage i follicular lymphoma, stage ii diffuse large b-cell lymphoma, stage ii follicular lymphoma, stage iii diffuse large b-cell lymphoma, stage iii follicular lymphoma, stage iv diffuse large b-cell lymphoma, stage iv follicular lymphoma